Table:
begin	end	state
1	5	non-cytoplasmic
6	26	transmembrane
27	35	cytoplasmic
36	66	transmembrane
67	83	non-cytoplasmic
84	104	transmembrane
105	111	cytoplasmic
112	133	transmembrane
134	222	non-cytoplasmic
223	246	transmembrane
247	275	cytoplasmic
276	297	transmembrane
298	306	non-cytoplasmic
307	325	transmembrane
326	335	cytoplasmic
336	360	transmembrane
361	366	non-cytoplasmic
367	388	transmembrane
389	397	cytoplasmic
398	440	transmembrane
441	450	non-cytoplasmic
451	459	cytoplasmic
460	481	transmembrane
482	485	non-cytoplasmic

Input:
>WP_054255660.1 NCBI__GCF_001298675.1:WP_054255660.1
MGFKPLPTAIAVALGLIIGFVIPVPAGVTPDAWHLLGLFVGTIAAIIGKALPIGALSIIA
IALVAVTGVTNDKAAGAINDALSSFSNSLIWLIGVSIMISRGIIKTGLGARIGYLFIAVW
GKKTIGIAYSLALSELILAPVTPSNTARGGGIIHPIMRAIAGSYGSDPEKGTQGRMGRYL
ALTNYHANPITSAMFITATAPNPLVVKLIADVTGAQISLSWGTWALAMLLPGLVALAVMP
LIIYMLHPPEIKSTPNAMQFAREKLKELGPISRGEITMFGVFAVLLVLWAGVPTFLFGPS
AAVDPTTTAFIGLSLCLVTGVLTWEDVIKEKSAWDTIVWFGALVMMATFLNKLGLITWFA
KSIETGIGHMGLSWVTASALLMLTYLYAHYMFASTTAHITAMFAAFYGAGLALGAPPLPF
ALMMAAASNIMMTLTHYATGTSPVIFGSGYTTLGEWWKTGFIMSLALLAIWLVVGGVWWK
VLGYW

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server